Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > Arcus Biosciences Inc. > Profile

Arcus Biosciences Inc. (RCUS)

Sector: Pharmaceutical Preparations

Hedge Fund Holdings

Filing Period:

Last updated on March 06, 2019, 2:22 pm based on SEC 13F filings Last update: March 06, 2019, 2:22 pm

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	Biotechnology Value Fund / BVF Inc Mark Lampert	2,411,623	$25,973	+128%	3.39%
2.	EcoR1 Capital Oleg Nodelman	1,223,495	$13,177	-46%	1.31%
3.	Hillhouse Capital Management Lei Zhang	342,128	$3,685	-56%	0.27%
4.	Partner Fund Management Christopher Medlock James	220,976	$2,380	-70%	0.06%
5.	Platinum Asset Management Kerr Neilson	146,193	$1,574	+53%	0.05%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Jaen	$11.80	10,000	Officer, Director	2,754,240	2018-11-13	Filing
Rosen	$15.48	10,650	Officer, Director	3,959,861	2018-08-28	Filing
Rosen	$14.92	800	Officer, Director	3,949,211	2018-08-27	Filing
Rosen	$14.48	7,157	Officer, Director	3,948,411	2018-08-27	Filing
Rosen	$13.40	4,954	Officer, Director	3,941,254	2018-08-24	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Meeder Asset Management Inc	342	$4	0%
2.	Quantitative Systematic Strategies Llc	0	$0	0%